Check out your Company Bowl for anonymous work chats.
We are pleased to announce the appointment of several key leaders to our Exec Team. George Golumbeski has been appointed as President and will serve as a Director on GRAIL’s Board, effective August 1, 2018. Onaiza Cadoret-Manier has been appointed as Chief Commercial Officer and Fred Kohler as Vice President of People. Angela Lai has been promoted to Chief Technology Officer. For more information, please see our press release http://glassdoor.com/slink.htm?key=vQIsE
Today, we announced initial results from our Circulating Cell-Free Genome Atlas (CCGA) study at the American Association for Cancer Research Annual Meeting (#AACR18). Initial results from our prototype assays support feasibility of highly specific blood test for early cancer detection. Learn more about these results here: http://glassdoor.com/slink.htm?key=vQf5J
We are excited to announce the appointment of Jennifer Cook as CEO of GRAIL, starting January 2, 2018. Bill Rastetter, who has been acting as interim CEO since August 2017, will continue in his role as chairman of the Board of Directors, focusing on governance of the company. Jennifer is an outstanding leader who brings a wealth of experience from the life sciences industry and we are thrilled she is joining GRAIL as the company moves into a pivotal year in 2018. For more information, please see our press release. http://glassdoor.com/slink.htm?key=vQLxE
While there’s tremendous work ahead of us, we’re excited by our progress as a #startup and today we’re taking a moment to celebrate our world-class team. Thanks for the recognition, @LinkedIn! We’re thrilled to be among #LinkedInTopCompanies and part of the inaugural #Startups list! http://glassdoor.com/slink.htm?key=vQLNN
